克罗恩病术前口服抗生素预防手术部位感染的随机对照试验
这项随机对照试验在335例拟行开腹肠切除的克罗恩病患者中,比较术前口服联合静脉抗生素与单用静脉抗生素对手术部位感染(SSI)的影响。结果显示总体和器官/腔隙SSI无显著差异,但切口SSI在联合组显著更低(7.4% vs 16.6%,P=0.01)。多因素分析中未口服抗生素是切口SSI的独立危险因素(OR 3.3,95%CI 1.3-8.3,P=0.01)。
要点
- 克罗恩病开腹肠切除术前口服联合静脉抗生素可降低切口SSI。
- 总体SSI和器官/腔隙SSI在联合组与单用静脉组间无显著差异。
- 未口服抗生素是切口SSI的独立危险因素(OR 3.3)。
核心结论
- 克罗恩病患者术前口服联合静脉抗生素有助于预防手术部位感染,主要降低切口SSI。
研究设计与样本
- 随机对照试验,在兵库医科大学开展,注册号000013369;335例拟行开腹肠切除的克罗恩病患者随机分为A组(口服+静脉抗生素)和B组(单用静脉抗生素)。
- 所有患者术前均接受枸橼酸匹可硫酸钠水合物机械性肠道准备。
- 主要终点为意向性治疗分析的手术部位感染发生率。
主要发现
- 总体SSI和器官/腔隙SSI发生率在两组间无显著差异。
- 切口SSI发生率A组为7.4%(12/163),B组为16.6%(27/162),差异有统计学意义(P=0.01)。
- 多因素分析显示,未口服抗生素是切口SSI的独立危险因素(OR 3.3,95%CI 1.3-8.3,P=0.01)。
临床怎么用
- 对拟行开腹肠切除的克罗恩病患者,可考虑术前口服联合静脉抗生素以降低切口SSI风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We investigated the efficacy of oral antimicrobial prophylaxis in patients undergoing surgery for Crohn disease. BACKGROUND: Although oral antibiotic prophylaxis with mechanical bowel preparation has been recommended for colorectal surgery, the use of this approach remains somewhat controversial. Moreover, the efficacy of this approach for inflammatory bowel disease also remains unclear. METHODS: This study was conducted as a randomized controlled trial at the Hyogo College of Medicine. The study protocols were registered with the University Hospital Medical Information Network Clinical Trials Registry (000013369). In this study, 335 patients with Crohn disease who were scheduled to undergo intestinal resection with an open approach were randomly assigned to either group A or group B. The patients in group A received both preoperative oral antibiotics and intravenous antimicrobial prophylaxis, and intravenous antimicrobial prophylaxis alone was given to the patients in group B. All patients underwent preoperative mechanical bowel preparation with sodium picosulfate hydrate. The primary endpoint of this study was the incidence of surgical site infection (SSI) according to an intention-to-treat analysis. RESULTS: Although the incidences of overall and organ/space SSI were not significantly different, the incidence of incisional SSI was significantly lower in group A (12/163; 7.4%) than in group B (27/162; 16.6%) (P = 0.01). In the multivariate analysis, the absence of oral antibiotic prophylaxis was an independent risk factor for incisional SSI (odds ratio: 3.3; 95% confidence interval: 1.3-8.3; P = 0.01). CONCLUSIONS: Combined oral and intravenous antimicrobial prophylaxis in patients with Crohn disease contributed to the prevention of SSI.
引用
- Uchino M, Ikeuchi H, Bando T, et al. Efficacy of Preoperative Oral Antibiotic Prophylaxis for the Prevention of Surgical Site Infections in Patients With Crohn Disease: A Randomized Controlled Trial. Ann Surg. 2019. PMID: 29064884. doi:10.1097/SLA.0000000000002567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。